700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02072

Synthetic patientMETA-24 · Day 170 · 35–44 · M · baseline S16Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
14%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S16
  2. Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 13.

Primary contributors, last 14 days
  • Nutritional resilience-6
  • Treatment adherence-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    46 min
    stable · +0.4 vs previous 14 d
    Sleep duration
    Wearable
    6.7 h
    stable · -0.0 vs previous 14 d
    Energy level
    Daily log
    6.2/10
    stable · +0.2 vs previous 14 d
    Steps
    Wearable
    4,709
    improving · +193 vs previous 14 d
    GI burden
    Companion
    20.5/100
    worsening · +2.5 vs previous 14 d
    Adherence
    Companion
    88.6 %
    stable · +0.3 vs previous 14 d
    Sleep quality
    Wearable
    49.1/100
    stable · -0.4 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    131 mg/dL
    stable · +4.6 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 71 from the failing basin, 22 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +11.3
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -6.1 next day
    Main detractors to watch
    • Low butyrate capacity
      hidden · steering -17.5
    • Alcohol
      perturbation · steering -9.8
    • Low microbial diversity
      hidden · steering -7.7
    • Ultra-processed food
      perturbation · steering -7.7
    • Alcohol
      detractor · GI +5 next day
    • Ultra-processed food
      detractor · GI +4.4 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -6.1supporter · 95%
    • Alcohol
      +5detractor · 95%
    • Ultra-processed food
      +4.4detractor · 95%
    • Simple carbohydrates
      +3.2detractor · 75%
    • Dietary fat load
      +2.9detractor · 69%
    • Insoluble fibre
      +2.1no signal · 33%
    • Histamine load
      -1.6no signal · 27%
    • Caffeine
      -0.7no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production ↓60
      • MicrobiomeButyrate capacity 29/100
      • MicrobiomeF. prausnitzii depleted
    • Mucosal barrier integrity ↓30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Inflammatory signalling ↓20
      • MicrobiomeBacteroides fragilis expansion
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 2.4 · butyrate capacity 29/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    67 ms
    Sleep
    7.3 h
    Steps
    4,469
    Resting HR
    58 bpm
    Daily log: GI score 21, nutritional resilience 56, adherence 89.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0228534%S14AD-05no change39
    P-0203133%S12AD-05improved47
    P-0209332%S05AD-05no change40
    P-0248337%S06BR-03no change64
    P-0228036%S07BR-03no change50
    P-0208735%S01BR-03no change40
    P-0252234%S01BR-03no change40
    P-0226733%S09BR-03no change45
    P-0263832%S01BR-03improved41
    P-0247947%S13DT-01improved48
    P-0268544%S16DT-01improved47
    P-0258642%S18DT-01improved56